🇺🇸 GILD — Gilead Sciences, Inc.

Healthcare Compra
← Volver

Precio actual

151,00 USD

Máx. histórico

157,29

205 días

Caída desde máximo

-4,00%

Rango 52 semanas

108,46 – 157,29

Variación hoy

-0,15%

Cierre anterior

151,22

Rango de hoy

149,23 – 151,19

Volumen hoy

5.977.099

Información
Nombre completo
Gilead Sciences, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
17.000
PER ⓘ
—
Dividend yield
2,17% (puede no estar actualizado)
Precio objetivo analistas
157,41 USD (puede no estar actualizado)
Primera cotización
22/01/1992
Precio actualizado
hace 2 días
Sobre la empresa

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Descovy, Genvoya, Odefsey, Sunlenca, Symtuza, and YeztugoFor the treatment of HIV-1 infection in patients. It also provides Epclusa, Livdelzi, and Vemlidy to treat chronic hepatitis C virus, primary biliary cholangitis, and chronic hepatitis B virus; Tecartus, a T-cell therapy for the treatment of adult patients; Trodelvy, an injection for intravenous use; and Yescarta, a suspension for intravenous infusion, is a CAR T-cell therapy for the treatment of adult patients. Further, it provides AmBisome, for the treatment of serious invasive fungal infections; and Veklury for the treatment of COVID-19. Additionally, the company engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company has collaboration agreements with Shenzhen Pregene Biopharma Co., Ltd.; Abingworth; Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company has a collaboration with Terray Therapeutics, Inc. to discover and develop small molecule therapies; and LEO Pharma to develop, manufacture, and commercialize the small molecule oral STAT6 program. The company was incorporated in 1987 and is headquartered in Foster City, California.

Dividendos repartidos Total últimos 12 meses: 3,2200 USD · Yield: 2,13%
Fecha de pago Importe por participación
15/06/2026 0,8200 USD
13/03/2026 0,8200 USD
15/12/2025 0,7900 USD
15/09/2025 0,7900 USD
13/06/2025 0,7900 USD
14/03/2025 0,7900 USD
13/12/2024 0,7700 USD
13/09/2024 0,7700 USD
14/06/2024 0,7700 USD
14/03/2024 0,7700 USD
14/12/2023 0,7500 USD
14/09/2023 0,7500 USD
14/06/2023 0,7500 USD
14/03/2023 0,7500 USD
14/12/2022 0,7300 USD
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
28/02/2019 65,20 65,66 64,73 65,02 -0,84% 1,43% 7.227.300
27/02/2019 65,11 66,11 65,01 65,57 +0,44% 1,69% 7.645.100
26/02/2019 65,25 65,82 65,09 65,28 -0,11% 1,12% 5.957.800
25/02/2019 66,06 66,06 65,23 65,35 -0,59% 1,26% 7.090.500
22/02/2019 65,61 65,96 65,33 65,74 +0,29% 0,96% 4.925.500
21/02/2019 66,93 66,96 65,24 65,55 -2,13% 2,57% 5.607.900
20/02/2019 66,67 67,29 66,52 66,98 +0,33% 1,15% 5.679.800
19/02/2019 67,34 67,77 66,65 66,76 -1,23% 1,66% 6.396.200
15/02/2019 66,71 67,69 66,50 67,59 +1,84% 1,78% 6.214.200
14/02/2019 66,13 66,79 65,68 66,37 +0,65% 1,68% 5.737.100
13/02/2019 65,57 66,67 65,49 65,94 +0,83% 1,80% 9.047.500
12/02/2019 64,78 65,44 63,96 65,40 -3,28% 2,28% 15.927.900
11/02/2019 67,62 67,97 67,29 67,62 +0,22% 1,01% 5.505.500
08/02/2019 66,92 67,61 66,34 67,47 +0,28% 1,90% 5.522.200
07/02/2019 68,43 68,77 66,92 67,28 -2,14% 2,70% 6.643.400
06/02/2019 67,58 69,31 67,27 68,75 +1,58% 3,02% 7.580.200
05/02/2019 67,75 69,02 66,75 67,68 -3,38% 3,35% 14.500.600
04/02/2019 69,86 70,26 69,22 70,05 +0,00% 1,49% 6.913.800
01/02/2019 70,00 70,50 69,36 70,05 +0,06% 1,63% 6.502.100
31/01/2019 69,81 70,32 69,08 70,01 +0,26% 1,78% 8.343.700
30/01/2019 69,42 70,30 68,60 69,83 +0,34% 2,45% 5.113.400
29/01/2019 68,07 69,96 68,04 69,59 +2,47% 2,82% 6.989.300
28/01/2019 68,42 69,00 67,36 67,91 -1,44% 2,40% 7.120.000
25/01/2019 68,17 69,28 68,10 68,90 +1,53% 1,73% 8.809.600
24/01/2019 68,43 68,46 67,52 67,86 -0,57% 1,37% 7.750.900
23/01/2019 68,52 69,51 67,82 68,25 -0,44% 2,47% 6.952.600
22/01/2019 68,74 68,82 68,02 68,55 -0,91% 1,16% 9.827.000
18/01/2019 69,24 69,58 68,51 69,18 +0,77% 1,55% 8.358.800
17/01/2019 67,54 68,96 67,46 68,65 +1,49% 2,22% 5.224.500
16/01/2019 68,27 68,87 67,55 67,64 -1,28% 1,93% 6.142.300